Health Products

Japan Weight Loss Blue, Japan Rapid Weight Loss Diet Pills Green, Japan Rapid Weight Loss Diet Pills Yellow

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Natural health products
Issue: Product Safety, Undeclared Substance
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

U.S. Food and Drug Administration (FDA)

Product names

  • Japan Weight Loss Blue
  • Japan Rapid Weight Loss Diet Pills Green
  • Japan Rapid Weight Loss Diet Pills Yellow

Manufacturer / Place of origin

According to the U.S. FDA alerts, Japan Rapid Weight Loss Diet Pills Green and Japan Rapid Weight Loss Diet Pills Yellow are distributed by Xiushentang. The manufacturer / distributor of Japan Weight Loss Blue is unknown.

Product description

These products are promoted for weight loss.

Reason for warning

The U.S. Food and Drug Administration (FDA) warned consumers not to use these weight loss products after they were found to contain undeclared drug ingredients as follows:

  • Japan Weight Loss Blue was found to contain sibutramine, unauthorized substances similar to sibutramine, and ephedrine alkaloids.
  • Japan Rapid Weight Loss Diet Pills Green was found to contain sibutramine and phenolphthalein.
  • Japan Rapid Weight Loss Diet Pills Yellow was found to contain phenolphthalein.

Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke. Unauthorized substances that are similar to sibutramine may pose similar health risks.

Ephedrine alkaloids are compounds derived from the plant Ephedra (Ma Huang). Ephedrine may also be chemically synthesized. Ephedrine is authorized for the relief of nasal congestion but is not authorized for sale in Canada as a stimulant or weight loss product.

Phenolphthalein was previously used as a laxative but is no longer authorized for sale in Canada because it may cause cancer.

According to the U.S. FDA alerts, these products are sold on various websites.

Possible side effects

In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.

Side effects associated with ephedrine include fast or abnormal heartbeat, chest pain, high blood pressure, dizziness, insomnia, and facial flushing.

Additional side effects associated with phenolphthalein include decreased blood pressure, skin rash and gastrointestinal bleeding.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

Health Canada
613-957-2983
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime